| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Ambrx (AMBX) | Stifel/ Wells Fargo Securities | $86.25 | n.a. | |||
| Aspen Aerogels (ASPN) | Barclays/ J.P. Morgan/ Citigroup | $86.25 | n.a. | |||
| Atento S.A. (TBA) | Morgan Stanley/ Credit Suisse/ Itaú BBA | $300.00 | n.a. | |||
| ProteinSimple (PRTN) | J.P. Morgan/ BofA Merrill Lynch | $86.25 | n.a. | |||
| Westlake Chemical Partners LP (WLKP) | Barclays/ UBS Investment Bank | $271.69 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Trustwave Holdings (TWAV) | Morgan Stanley/ J.P. Morgan Securities/ Barclays Capital | 6.25 | $15.00 | $17.00 | $100.00 | 1-Star |
| New Terms | ||||||
| Arista Networks (ANET) | Morgan Stanley/ Citigroup | $241.00 | n.a. | |||
| CardioDx (CDX) | Jefferies/ Piper Jaffray | $86.25 | n.a. | |||
| Dorian LPG (LPG) | J.P. Morgan/ UBS Investment Bank | 7.11 | $18.00 | $20.00 | $135.00 | N/C |
| ETRE REIT (ECAV) | Sandler O’Neill + Partners, L.P. | 3.71 | $16.00 | $16.00 | $59.33 | n |
| GasLog Partners LP (GLOP) | Citigroup | 8.40 | $19.00 | $21.00 | $168.00 | 2-Stars |
| GlobeImmune (GBIM) | Aegis Capital Corp. | 2.19 | $15.00 | $17.00 | $35.00 | n.a. |
| Mapi – Pharma Ltd. (MAPI) | Aegis Capital Corp. | 2.67 | $13.00 | $15.00 | $37.31 | n.a. |
| Medical Transcription Billing (MTBC) | Summer Street Research Partners | $35.00 | n.a. | |||
| Memorial Resource Development (MRD) | Citigroup/ Barclays/ BofA Merrill Lynch/ BMO Capital Markets/ Goldman Sachs/ Raymond James/ RBC Capital Markets/ Wells Fargo Securities | $700.00 | n.a. | |||
| PBF Logistics LP (PBFX) | Barclays/ UBS Investment Bank | 13.75 | $19.00 | $21.00 | $275.00 | 3-Stars |
| SCYNEXIS (SCYX) | RBC Capital Markets/ Canaccord Genuity | 6.20 | $10.00 | $10.00 | $62.00 | 1-Star |
| SD COMPANY (SDPI) | Roth Capital Partners, LLC | 5.00 | $5.00 | $7.00 | $30.00 | n.a. |
| ServisFirst Bancshares (SFBS) | Sandler ONeill & Partners | 0.63 | $91.00 | $93.00 | $57.50 | n.a. |
| Tuniu (TOUR) | Morgan Stanley/ Credit Suisse/ China Renaissance | 8.00 | $9.00 | $11.00 | $80.00 | 2-Stars |
| N/C = No Call – stock traded on the Norwegian OTC List under the symbol “DORIAN” | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of April 28, 2014 | Manager(s) | Offered | Raised | Price | 5/2/14 | Change |
| Papa Murphy’s Holdings (FRSH) | Jefferies/ Baird/ Wells Fargo Securities | 5.83 | $64.17 | $11.00 | $11.05 | 0.45% |
| SCYNEXIS (SCYX) | RBC Capital Markets/ Canaccord Genuity | 6.20 | $62.00 | $10.00 | $9.80 | -2.00% |
| Ares Management, L.P. (ARES) |
J.P. Morgan/ BofA Merrill Lynch/ Goldman Sachs/ Morgan Stanley/ Wells Fargo Securities | 11.36 | $215.91 | $19.00 | $18.60 | -2.11% |
| Aldeyra Therapeutics (ALDX) | Aegis Capital Corp | 1.50 | $12.00 | $8.00 | $7.20 | -10.00% |
